Skip to main content
OpenTrials
Completed

NCT Number: NCT04228562

Consumer Motivation for Disease Prevention 2 (Clear Labels)

The purpose of this study is to examine (1) how the causal structure of a disease influences people's disease prevention decisions; and (2) how the causal structure of a disease interacts with people's regret anticipation in determining their disease prevention decisions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chinese University of Hong Kong

Hong Kong

About this study

People sometimes have to deliberate on whether or not to remove a risk factor that may potentially cause a disease in the future. When a modifiable risk factor (say, X) is the only factor that causes a disease, the decision to remove it may simply depend on the probabilistic relationship between X and an outcome, as well as the cost of removing X. However, little is known when other factors that are out of the decision-maker's control are also present. The main question being asked here is how does the presence of such non-modifiable factors change people's decision to remove X.

Specifically, the investigators consider two cases: a disease caused by a single modifiable risk factor (say X) and a disease caused by two risk factors -- a modifiable factor (X) and a non-modifiable factor (Y). In both cases, the removal of X can result in a meaningful reduction in overall disease risk. It is hypothesized that even when the magnitude of overall risk reduction brought by the removal of X is the same in the two cases, people would have a lower motivation to remove X in the latter case.

The investigators also examine how the presence of a non-modifiable risk factor interacts with the respondents' regret anticipation to influence their decision to remove X. In the context of the current research, regret anticipation could take one of the following forms: (a) feel regretful if one decides not to remove X and later develops the disease (b) feel regretful if one decides to remove X but still develops the disease. The investigators expect (a) to moderate the effect of non-modifiable risk factor on motivation to remove X.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • students currently studying at the Chinese University of Hong Kong

Exclusion criteria

  • None

Treatment and study plan

non-modifiable factor

Other

the presence of an uncontrollable / unremovable risk factor for a disease

induction of anticipated regret

Other

higher level of elaboration on potential regret

Primary outcomes

  1. Decision to remove X

    Time frame: Day 1: When responding to the questionnaire

    The decision to remove X (yes vs. no)

Other outcomes

  1. Anticipated regret

    Time frame: Day 1: When responding to the questionnaire

    The exact question is: Some people may engage in the following thoughts when they make their decisions: "I may regret if I do not remove X and end up getting the disease" OR "I may regret if I remove X but still get the disease." To what extent have you engaged in any of these thoughts? (Measurement scale: 1 = not at all; 7 = a lot)

  2. Judgment of whether the removal of X is an opportunity to improve earnings

    Time frame: Day 1: When responding to the questionnaire

    The exact question is: Do you think the decision to remove X is an opportunity for you to improve your final earnings? (Measurement scale: 1 = not a good opportunity at all; 7 = a very good opportunity")

  3. Sense of control over the final outcome

    Time frame: Day 1: When responding to the questionnaire

    The exact question is: Do you think you have control over the outcome through your decision of whether or not to remove X? (Measurement scale: 1 = I have very little control… 7 = I have a lot of control)

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Collaborators

  • University of Toronto

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jan 14, 2020
Registry last updated
Sep 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.